The Dyrk1b–/– mice on CD showed significant reduction in hepatic TAG (Supplemental Figure 5, J and K) and were protected against Dyrk1b-dependent pathways that induce NAFLD. This evidence concerns the gene DYRK1B and metabolic dysfunction-associated steatotic liver disease.